Month: August 2025
BOCA RATON, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) — On August 20, 2025, NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT) successfully closed an offering of 2,000,000 depositary shares (the “Depositary Shares”), each representing a 1/40th interest in a share of the Company’s 8.500% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), with a liquidation preference of $1,000 per share (equivalent to $25.00 per Depositary Share). The offering generated approximately $48.357 million in net proceeds to the Company. In addition, the Company granted the underwriters a 30-day option to purchase up to an additional 150,000 Depositary Shares at the public offering price less the applicable underwriting discount. The newly issued Series B Preferred Stock will pay (and the holders...
Safety Shot Secures $30 Million Strategic Investment From BONK Core Team and FalconX
Written by Customer Service on . Posted in Public Companies.
SCOTTSDALE, AZ, Aug. 25, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has successfully priced a $30 million financing, anchored by a consortium of strategic investors including FalconX, the transaction consists of a registered direct offering for approximately $5 million in cash and a concurrent private placement for $25 million paid for in BONK tokens by the BONK founding members, with all shares priced at $0.46 per share.
Demonstrating significant investor demand for the Company’s new strategic direction, this powerful backing from some of the most respected names in both traditional and digital asset finance provides Safety Shot with a fortified balance sheet to aggressively execute on its growth strategy.
For shareholders, we believe this transaction represents...
Forager Capital Management Submits Fully Financed Proposal to Acquire Quipt Home Medical for $3.10 Per Share in Cash
Written by Customer Service on . Posted in Mergers And Acquisitions.
Acquisition Proposal is Fully Financed and Requires No Further Diligence—Ready for Definitive Documents
Prepared to Improve Offer Upon Constructive Engagement from Board
BIRMINGHAM, Ala., Aug. 25, 2025 (GLOBE NEWSWIRE) — Forager Capital Management (“Forager”), one of the largest shareholders of Quipt Home Medical Corp. (“Quipt”) (NASDAQ: QIPT; TSX: QIPT), with beneficial ownership of 9.7%, today announced it has submitted a proposal to acquire all outstanding shares of Quipt for $3.10 per share in cash (the “Acquisition Proposal”).
The Acquisition Proposal is not subject to any due diligence or financing conditions and is capable of being executed immediately. The offer represents a 120% premium to Quipt’s unaffected share price of $1.41 at close on May 19, 2025, the trading day prior to Forager’s prior proposal being made public.
In...
VERSES® Receives Patent for Specifying Domain Models with Active Inference Agents
Written by Customer Service on . Posted in Public Companies.
Patent Illustrates Additional Component of Company’s Commercial Strategy
VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, today announces that a patent was issued by the US Patent and Trademark office to the VERSES team.
The patent, entitled, “A Method and System for Specifying an Active Inference based agent using Natural Language”, presents a novel approach for designing domain models that is designed to enable software agents to generate predictions and carry out domain-specific tasks.
“This patent represents just a glimpse of how VERSES is turning active inference into usable, scalable technology,” said Hari Thiruvengada, Chief Technology Officer of VERSES....
AITX’s RAD Launches Logistics Market Solution With ROAMEO
Written by Customer Service on . Posted in Public Companies.
Client Feedback from Complete RAD Security Solution Offers Significant Potential
Detroit, Michigan, Aug. 25, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), today announced an expanded emphasis on serving the logistics sector. This initiative is driven by strong client response to the recent addition of ROAMEO™ Gen 4 and SARA™ to RAD’s security solutions. With deep industry ties, a proven track record, and the breadth of its complete ecosystem, the Company sees significant opportunities for expansion.
As part of the support for this effort the company has issued a fully refreshed Logistics Solution brochure, that can be found here: www.radsecurity.com/brochures/RAD-Logistics-2508.pdf
“Encouragement...
Mama’s Creations to Host Second Quarter Fiscal 2026 Earnings Call on September 8 at 4:30 p.m. Eastern Time
Written by Customer Service on . Posted in Public Companies.
EAST RUTHERFORD, NJ, Aug. 25, 2025 (GLOBE NEWSWIRE) — Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, will release financial results for the fiscal second quarter ended July 31, 2025 after market close on September 8, 2025.
Management will host an investor conference call at 4:30 p.m. Eastern time on Monday, September 8, 2025 to discuss the Company’s second quarter fiscal 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
Q2 FY2026 Earnings Conference Call
Date: Monday, September 8, 2025 Time: 4:30 p.m. Eastern time U.S. Dial-in: 1-877-451-6152International Dial-in: 1-201-389-0879Conference ID: 13755525Webcast: MAMA Q2 FY2026 Earnings Conference Call
Please...
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
Written by Customer Service on . Posted in Public Companies.
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026
Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion
More than 50 million people affected by acne in US each year, with market valued at $5.7 billion in 2024WOBURN, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced that the final patient in its Phase 2b clinical trial evaluating Ameluz® (aminolevulinic acid hydrochloride) for the treatment of moderate to severe acne vulgaris (AV) completed participation on August 22, 2025.
Acne vulgaris is a common skin condition characterized by inflammatory and non-inflammatory...
Schouw & Co. share buy-back programme, week 34 2025
Written by Customer Service on . Posted in Mergers And Acquisitions.
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
Trading day
No. of shares
Average price
Amount
Accumulated until 15 August 2025
99,500
597.56
59,457,510
Monday, 18 August 2025
2,000
582.18
1,164,360
Tuesday, 19 August 2025
1,500
603.63
905,445
Wednesday, 20 August 2025
1,500
600.17
900,255
Thursday, 21 August 2025
1,500
597.75
896,625
Friday,...
Danforth Advisors Acquires PharmaDirections, Expanding its Integrated Drug Development Services from Discovery through Commercialization
Written by Customer Service on . Posted in Mergers And Acquisitions.
WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) — Danforth Advisors, LLC, today announced the acquisition of PharmaDirections, Inc., a full-spectrum development partner to life science companies, expanding its integrated capabilities from discovery through commercialization.
Founded in 2003, PharmaDirections was a pioneer of the virtual drug development model. The company brings veteran program leaders and more than 150 specialists to support strategic planning and execution from company incubation to approval. The team’s expertise spans discovery, early to late stage non-clinical and clinical development, translational sciences, and all areas of CMC with full program and alliance management oversight across all major modalities and therapeutic areas. Michelle Higgin, PhD, will continue in her role as CEO.
“PharmaDirections and...
GCL’s Subsidiary Completes Compulsory Acquisition and Delisting of Ban Leong Technologies Limited
Written by Customer Service on . Posted in Mergers And Acquisitions.
SINGAPORE, Aug. 25, 2025 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (NASDAQ: GCL) (“GCL”), a leading provider of games and entertainment and the indirect parent company of Epicsoft Asia Pte. Ltd. (“Epicsoft Asia” or “Offeror”), today announced that Epicsoft Asia has completed the compulsory acquisition of Ban Leong Technologies Limited (“Ban Leong”) on August 25, 2025, and Ban Leong will be delisted from the Singapore Stock Exchange on August 26, 2025.
For over three decades, Ban Leong has been a leading distributor of technology products across Asia, offering an extensive portfolio that includes IT accessories, gaming components, smart (IoT) devices, and commercial solutions. The company is an authorized distributor for more than 50 globally recognized brands, including Razer, Nvidia, Samsung, Huawei, TP-Link, and LG. Leveraging...
